amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride

Labeler: dr.reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amlodipine besylate and benazepril hydrochloride
Generic Name amlodipine besylate and benazepril hydrochloride
Labeler dr.reddy's laboratories limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

amlodipine besylate 10 mg/1, benazepril hydrochloride 40 mg/1

Manufacturer
Dr.Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-586
Product ID 55111-586_2b57e667-c854-2ed1-32f9-b06c6fea1930
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090149
Listing Expiration 2026-12-31
Marketing Start 2011-07-05

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] decreased blood pressure [pe] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111586
Hyphenated Format 55111-586

Supplemental Identifiers

RxCUI
898346 898359
UNII
864V2Q084H N1SN99T69T

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Generic Name amlodipine besylate and benazepril hydrochloride (source: ndc)
Application Number ANDA090149 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (55111-586-01)
  • 500 CAPSULE in 1 BOTTLE (55111-586-05)
  • 30 CAPSULE in 1 BOTTLE (55111-586-30)
source: ndc

Packages (3)

Ingredients (2)

amlodipine besylate (10 mg/1) benazepril hydrochloride (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b57e667-c854-2ed1-32f9-b06c6fea1930", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898346", "898359"], "spl_set_id": ["f12f18bb-7ddb-e7dc-4edd-32f4ac212bca"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (55111-586-01)", "package_ndc": "55111-586-01", "marketing_start_date": "20110705"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (55111-586-05)", "package_ndc": "55111-586-05", "marketing_start_date": "20110705"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (55111-586-30)", "package_ndc": "55111-586-30", "marketing_start_date": "20110705"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "55111-586_2b57e667-c854-2ed1-32f9-b06c6fea1930", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "55111-586", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Dr.Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "ANDA090149", "marketing_category": "ANDA", "marketing_start_date": "20110705", "listing_expiration_date": "20261231"}